Technichem Organics Ipo
Objects of the Issue
Funding of capital expenditure requirements of our Company towards setting up of a new plant named as “Plant –4”;
Repayment or prepayment, in full or in part, of certain borrowings availed by our Company from banks, financial institutions and non-banking financial companies;
General corporate purposes;
Technichem Organics IPO Review
IPO Watch – May Apply
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Shreni Shares Limited
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 2,000 | ₹1,10,000 |
| Retail Maximum | 1 | 2,000 | ₹1,10,000 |
| S-HNI Minimum | 2 | 4,000 | ₹2,20,000 |
| IPO Open Date: | December 31, 2024 |
| IPO Close Date: | January 2, 2025 |
| Basis of Allotment: | January 3, 2025 |
| Refunds: | January 6, 2025 |
| Credit to Demat Account: | January 6, 2025 |
| IPO Listing Date: | January 7, 2025 |
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹67.02 | ₹63.14 | ₹3.42 | ₹44.17 |
| 2023 | ₹50.36 | ₹48.64 | ₹1.73 | ₹44.25 |
| 2024 | ₹46.39 | ₹40.52 | ₹4.73 | ₹52.47 |
| KPI | Values |
| ROE: | 27.39% |
| ROCE: | 22.57% |
| EBITDA Margin: | 20.54% |
| PAT Margin: | 10.19% |
| Debt to equity ratio: | 0.90 |
| Earning Per Share (EPS): | ₹3.71 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 24.09% |
| Net Asset Value (NAV): | ₹15.41 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Ami Organics Limited | 11.91 | 108.93 | 6.47% | 183.05 | – Cr. |
| Anupam Rasayan India Limited | 10.84 | 72.12 | 4.29% | 249.26 | – Cr. |
| Chemcrux Enterprises Ltd | 5.70 | 35.95 | 12.60% | 48.79 | – Cr. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date: | December 31, 2024 |
| IPO Close Date: | January 2, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹52 to ₹55 Per Share |
| Issue Size: | Approx ₹25.25 Crores |
| Fresh Issue: | Approx ₹25.25 Crores |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |